According to the latest report by IMARC Group, titled “Enteric Softgel Capsules Market Size: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027″, The global enteric softgel capsules market reached a value of US$ 2,379 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 3,067 Million by 2027, exhibiting a CAGR of 4.23% during 2022-2027.

Enteric softgel capsules represent extended-release capsules used for stabilizing the reaction of acid-sensitive medication in the human stomach during digestion. They are sealed hermetically and contain liquid or semi-solid medicinal drugs inside a gelatin-based shell coating. These capsules aid in preserving the active pharmaceutical ingredients (API) and inhibiting gastric irritation and reflux. Owing to this, enteric softgel capsules are widely utilized as multivitamin supplements to prevent or treat vitamin or nutrient deficiency caused by unhealthy diet and illnesses or during pregnancy.

Report Metric

Historical: 2016-2021

Base Year: 2020

Forecast Year: 2022-2027

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Request Free Sample Report: https://www.imarcgroup.com/enteric-softgel-capsules-market/requestsample

Market Trends:

The significant growth in the pharmaceutical industry and elevating healthcare expenditures of consumers are primarily driving the enteric softgel capsules market. Moreover, the increasing public health consciousness and the growing acceptance of nutritional supplements are further bolstering the market growth. Besides this, several new variants are being produced using starch and other plant-based sources to meet the dietary requirements of vegan consumers. Additionally, the development of innovative non-gelatin-based variants is also positively influencing the market growth. Apart from this, the rising geriatric population, who are more susceptible to chronic ailments, is further augmenting the need for enteric softgel capsules. Apart from this, extensive R&D activities to improve the bioavailability of these products and the expansion of online pharmacies are also anticipated to stimulate the market growth for enteric softgel capsules in the coming years.

Global Enteric Softgel Capsules Market 2022-2027 Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

Competitive Landscape Key Player:

Aenova Group, BASF SE , Catalent Inc, Colorcon Inc., Fuji Capsule Co. Ltd., Lonza Group AG, NOW Foods, ProCaps, Super Spectrim and Thermo Fisher Scientific Inc.

The report has segmented the market on the basis on type, application and distribution channel.

Breakup by Type:

Gelatin CapsulesNon-Gelatin Softgel Capsules

Breakup by Application:

Health SupplementsPharmaceuticals

Breakup by Distribution Channel:

Supermarkets and HypermarketsPharmacy and Drug StoresOnline Stores

Breakup by Region:

North America: (United States, Canada)Asia Pacific: (China, Japan,India, South Korea, Australia, Indonesia, Others)Europe: (Germany, France,United Kingdom, Italy, Spain, Russia, Others)Latin America: (Brazil,

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/enteric-softgel-capsules-market

If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

Key highlights of the report:

Market Performance (2016-2020)Market Outlook (2022- 2027)Porter’s Five Forces AnalysisMarket Drivers and Success FactorsSWOT AnalysisValue ChainComprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us

IMARC Group30 N Gould St Ste RSheridan, WY 82801 USAEmail: Sales@imarcgroup.comTel No:(D) +91 120 433 0800 |Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800